Restricted accessResearch articleFirst published online 2010-09
Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Blood Isolates: Clonal Spread of Staphylococcal Cassette Chromosome mec Type IVA Between the Community and the Hospital
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is becoming increasingly common worldwide. The purpose of this study was to identify the prevalence and molecular characteristics of MRSA bloodstream isolates in hospitals. Clinical data from patients with MRSA bacteremia between 2003 and 2005 were collected. Isolates were classified as hospital-acquired (HA-MRSA), health care-associated (HCA-MRSA), or CA-MRSA according to the time of isolation and the risk factors for colonization. Available strains were tested for the presence of mecA, staphylococcal cassette chromosome mec (SCCmec), and by multilocus sequence test. Among 129 cases, 78 nonduplicated isolates were analyzed. The proportion of CA-MRSA, HCA-MRSA, and HA-MRSA was 2.6% (2), 23.1% (18), and 74.4% (58), respectively. According to multilocus sequence test and SCCmec, there were seven genotypes with sequence types (STs) and SCCmec types. The predominant genotype, ST5-MRSA-II, was found in 57.7% (45). All type IVA isolates was ST72 (9), and ST72-MRSA-IVA was identified in CA-MRSA (2, 100%), HCA-MRSA (1, 5.6%), and HA-MRSA (6, 10.3%), respectively. In summary, CA-MRSA bacteremia was not common in our hospital during the period.
Get full access to this article
View all access options for this article.
References
1.
BabaT., TakeuchiF., KurodaM., YuzawaH., AokiK., OguchiA., NagaiY., IwamaN., AsanoK., NaimiT., KurodaH., CuiL., YamamotoK., HiramatsuK.2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet, 359:1819–1827.
2.
BoneR.C., BalkR.A., CerraF.B., DellingerR.P., FeinA.M., KnausW.A., ScheinR.M., SibbaldW.J.1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101:1644–1655.
3.
ChaH.Y., MoonD.C., ChoiC.H., OhJ.Y., JeongY.S., LeeY.C., SeolS.Y., ChoD.T., ChangH.H., KimS.W., LeeJ.C.2005. Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital. J. Clin. Microbiol., 43:3610–3614.
4.
ChambersH.F.2001. The changing epidemiology of Staphylococcus aureus?Emerg. Infect. Dis., 7:178–182.
5.
ChungH.J., JeonH.S., SungH., KimM.N., HongS.J.2008. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J. Clin. Microbiol., 46:991–995.
6.
Clinical, Laboratory Standards Institute. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M07-A88th. Wayne, PA.
7.
CrisostomoM.I., WesthH., TomaszA., ChungM., OliveiraD.C., de LencastreH.2001. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. U.S.A., 98:9865–9870.
8.
EnrightM.C., DayN.P., DaviesC.E., PeacockS.J., SprattB.G.2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol., 38:1008–1015.
9.
FeilE.J., LiB.C., AanensenD.M., HanageW.P., SprattB.G.2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol., 186:1518–1530.
FriedmanN.D., KayeK.S., StoutJ.E., McGarryS.A., TrivetteS.L., BriggsJ.P., LammW., ClarkC., MacFarquharJ., WaltonA.L., RellerL.B., SextonD.J.2002. Health care—associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med., 137:791–797.
12.
GoeringR.V., WintersM.A.1992. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol., 30:577–580.
13.
HiramatsuK.1995. Molecular evolution of MRSA. Microbiol. Immunol., 39:531–543.
14.
International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). 2009. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob. Agents Chemother., 53:4961–4967.
15.
KimH.B., ParkW.B., LeeK.D., ChoiY.J., ParkS.W., OhM.D., KimE.C., ChoeK.W.2003. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J. Clin. Microbiol., 41:2279–2281.
16.
KimJ.S., SongW., KimH.S., ChoH.C., LeeK.M., ChoiM.S., KimE.C.2006. Association between the methicillin resistance of clinical isolates of Staphylococcus aureus, their staphylococcal cassette chromosome mec (SCCmec) subtype classification, and their toxin gene profiles. Diagn. Microbiol. Infect. Dis., 56:289–295.
17.
KoK.S., KimY.S., SongJ.H., YeomJ.S., LeeH., JungS.I., JeongD.R., KimS.W., ChangH.H., KiH.K., MoonC., OhW.S., PeckK.R., LeeN.Y.2005. Genotypic diversity of methicillin-resistant Staphylococcus aureus isolates in Korean hospitals. Antimicrob. Agents Chemother., 49:3583–3585.
18.
KoK.S., LeeJ.Y., SuhJ.Y., OhW.S., PeckK.R., LeeN.Y., SongJ.H.2005. Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries. J. Clin. Microbiol., 43:421–426.
19.
LinaG., PiemontY., Godail-GamotF., BesM., PeterM.O., GauduchonV., VandeneschF., EtienneJ.1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis., 29:1128–1132.
20.
MaX.X., ItoT., TiensasitornC., JamklangM., ChongtrakoolP., Boyle-VavraS., DaumR.S., HiramatsuK.2002. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother., 46:1147–1152.
21.
MilheiriçoC., OliveiraD.C., de LencastreH.2007. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob. Agents Chemother., 51:3374–3377.
22.
MorinC.A., HadlerJ.L.2001. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J. Infect. Dis., 184:1029–1034.
23.
NaimiT.S., LeDellK.H., Como-SabettiK., BorchardtS.M., BoxrudD.J., EtienneJ., JohnsonS.K., VandeneschF., FridkinS., O'BoyleC., DanilaR.N., LynfieldR.2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA, 290:2976–2984.
24.
OkumaK., IwakawaK., TurnidgeJ.D., GrubbW.B., BellJ.M., O'BrienF.G., CoombsG.W., PearmanJ.W., TenoverF.C., KapiM., TiensasitornC., ItoT., HiramatsuK.2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol., 40:4289–4294.
25.
OliveiraD.C., de LencastreH.2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 46:2155–2161.
26.
OliveiraD.C., TomaszA., de LencastreH.2001. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb. Drug Resist., 7:349–361.
27.
OliveiraD.C., TomaszA., de LencastreH.2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis., 2:180–189.
28.
ParkC., LeeD.G., KimS.W., ChoiS.M., ParkS.H., ChunH.S., ChoiJ.H., YooJ.H., ShinW.S., KangJ.H., KimJ.H., LeeS.Y., KimS.M., PyunB.Y.2007. Predominance of community-associated methicillin-resistant Staphylococcus aureus strains carrying staphylococcal chromosome cassette mec type IVA in South Korea. J. Clin. Microbiol., 45:4021–4026.
29.
RobinsonD.A., EnrightM.C.2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 47:3926–3934.
30.
Said-SalimB., MathemaB., KreiswirthB.N.2003. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect. Control Hosp. Epidemiol., 24:451–455.
31.
SorianoA., MartinezJ.A., MensaJ., MarcoF., AlmelaM., Moreno-MartinezA., SanchezF., MunozI., Jimenez de AntaM.T., SorianoE.2000. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin. Infect. Dis., 30:368–373.
32.
TacconelliE., VenkataramanL., De GirolamiP.C., EMD.A.2004. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus health care-associated strains. J. Antimicrob. Chemother., 53:474–479.
